Cargando…

Long-Term Therapy With Wu-Ling-San, a Popular Antilithic Chinese Herbal Formula, Did Not Prevent Subsequent Stone Surgery: A Nationwide Population-Based Cohort Study

Traditional Chinese herbal medicine (CHM), which is widely used to treat pain and urolithiasis, is a promising therapy for urinary stone prevention. This study investigated the clinical efficacy of a popular CHM, Wu-Ling-San (WLS), in Taiwan for the prophylaxis of recurrent nephrolithiasis as assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, San-Yuan, Chen, Huey-Yi, Tsai, Kao-Sung, Chiang, Jen-Huai, Muo, Chih-Hsin, Sung, Fung-Chang, Chen, Yung-Hsiang, Chen, Wen-Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798738/
https://www.ncbi.nlm.nih.gov/pubmed/27932514
http://dx.doi.org/10.1177/0046958016681148
_version_ 1783297890378055680
author Wu, San-Yuan
Chen, Huey-Yi
Tsai, Kao-Sung
Chiang, Jen-Huai
Muo, Chih-Hsin
Sung, Fung-Chang
Chen, Yung-Hsiang
Chen, Wen-Chi
author_facet Wu, San-Yuan
Chen, Huey-Yi
Tsai, Kao-Sung
Chiang, Jen-Huai
Muo, Chih-Hsin
Sung, Fung-Chang
Chen, Yung-Hsiang
Chen, Wen-Chi
author_sort Wu, San-Yuan
collection PubMed
description Traditional Chinese herbal medicine (CHM), which is widely used to treat pain and urolithiasis, is a promising therapy for urinary stone prevention. This study investigated the clinical efficacy of a popular CHM, Wu-Ling-San (WLS), in Taiwan for the prophylaxis of recurrent nephrolithiasis as assessed by surgical stone treatment via a nationwide population-based cohort study. The National Health Insurance Research Database, 2000–2010, which included one million patient records. All patients diagnosed with stone disease at the beginning of the study. The matched controls (4-fold the number of WLS patients) were stone patients who did not take WLS. Data analysis included the stone surgeries following the first treatment. We enrolled 11 900 patients with stone disease, and the incidence of stone patients in this database was 1.19%. The prevalence of comorbidities such as benign prostate hyperplasia, chronic kidney disease, diabetes mellitus, and urinary tract infection, but not hypertension, was significantly higher in WLS users. Several patients in both groups were prescribed potassium citrate. The stone treatment rate was significantly higher in WLS users (17.85%) than in the non-WLS users (14.47%). WLS users with an associated comorbidity had a higher treatment rate than the non-WLS users: 21.05% versus 16.70%, respectively. The surgery rate for upper urinary tract stones was higher in WLS users than in the non-WLS users (adjusted hazard ratio, 1.28; 95% confidence interval, 1.08-1.52; P < .05). The stone treatment rate (52.79%) was significantly higher in patients who used a very high amount of WLS (adjusted hazard ratio, 3.02; 95% confidence interval, 2.30-3.98). Stone patients using a high amount of WLS use had a high stone surgical rate. Long-term therapy with WLS did not have a preventive effect on stone surgical treatment. Long-term potassium citrate therapy as a preventive measure appeared to be underutilized in this study.
format Online
Article
Text
id pubmed-5798738
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-57987382018-02-12 Long-Term Therapy With Wu-Ling-San, a Popular Antilithic Chinese Herbal Formula, Did Not Prevent Subsequent Stone Surgery: A Nationwide Population-Based Cohort Study Wu, San-Yuan Chen, Huey-Yi Tsai, Kao-Sung Chiang, Jen-Huai Muo, Chih-Hsin Sung, Fung-Chang Chen, Yung-Hsiang Chen, Wen-Chi Inquiry Healthcare in the National Health Insurance System in Taiwan Traditional Chinese herbal medicine (CHM), which is widely used to treat pain and urolithiasis, is a promising therapy for urinary stone prevention. This study investigated the clinical efficacy of a popular CHM, Wu-Ling-San (WLS), in Taiwan for the prophylaxis of recurrent nephrolithiasis as assessed by surgical stone treatment via a nationwide population-based cohort study. The National Health Insurance Research Database, 2000–2010, which included one million patient records. All patients diagnosed with stone disease at the beginning of the study. The matched controls (4-fold the number of WLS patients) were stone patients who did not take WLS. Data analysis included the stone surgeries following the first treatment. We enrolled 11 900 patients with stone disease, and the incidence of stone patients in this database was 1.19%. The prevalence of comorbidities such as benign prostate hyperplasia, chronic kidney disease, diabetes mellitus, and urinary tract infection, but not hypertension, was significantly higher in WLS users. Several patients in both groups were prescribed potassium citrate. The stone treatment rate was significantly higher in WLS users (17.85%) than in the non-WLS users (14.47%). WLS users with an associated comorbidity had a higher treatment rate than the non-WLS users: 21.05% versus 16.70%, respectively. The surgery rate for upper urinary tract stones was higher in WLS users than in the non-WLS users (adjusted hazard ratio, 1.28; 95% confidence interval, 1.08-1.52; P < .05). The stone treatment rate (52.79%) was significantly higher in patients who used a very high amount of WLS (adjusted hazard ratio, 3.02; 95% confidence interval, 2.30-3.98). Stone patients using a high amount of WLS use had a high stone surgical rate. Long-term therapy with WLS did not have a preventive effect on stone surgical treatment. Long-term potassium citrate therapy as a preventive measure appeared to be underutilized in this study. SAGE Publications 2016-12-07 /pmc/articles/PMC5798738/ /pubmed/27932514 http://dx.doi.org/10.1177/0046958016681148 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Healthcare in the National Health Insurance System in Taiwan
Wu, San-Yuan
Chen, Huey-Yi
Tsai, Kao-Sung
Chiang, Jen-Huai
Muo, Chih-Hsin
Sung, Fung-Chang
Chen, Yung-Hsiang
Chen, Wen-Chi
Long-Term Therapy With Wu-Ling-San, a Popular Antilithic Chinese Herbal Formula, Did Not Prevent Subsequent Stone Surgery: A Nationwide Population-Based Cohort Study
title Long-Term Therapy With Wu-Ling-San, a Popular Antilithic Chinese Herbal Formula, Did Not Prevent Subsequent Stone Surgery: A Nationwide Population-Based Cohort Study
title_full Long-Term Therapy With Wu-Ling-San, a Popular Antilithic Chinese Herbal Formula, Did Not Prevent Subsequent Stone Surgery: A Nationwide Population-Based Cohort Study
title_fullStr Long-Term Therapy With Wu-Ling-San, a Popular Antilithic Chinese Herbal Formula, Did Not Prevent Subsequent Stone Surgery: A Nationwide Population-Based Cohort Study
title_full_unstemmed Long-Term Therapy With Wu-Ling-San, a Popular Antilithic Chinese Herbal Formula, Did Not Prevent Subsequent Stone Surgery: A Nationwide Population-Based Cohort Study
title_short Long-Term Therapy With Wu-Ling-San, a Popular Antilithic Chinese Herbal Formula, Did Not Prevent Subsequent Stone Surgery: A Nationwide Population-Based Cohort Study
title_sort long-term therapy with wu-ling-san, a popular antilithic chinese herbal formula, did not prevent subsequent stone surgery: a nationwide population-based cohort study
topic Healthcare in the National Health Insurance System in Taiwan
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798738/
https://www.ncbi.nlm.nih.gov/pubmed/27932514
http://dx.doi.org/10.1177/0046958016681148
work_keys_str_mv AT wusanyuan longtermtherapywithwulingsanapopularantilithicchineseherbalformuladidnotpreventsubsequentstonesurgeryanationwidepopulationbasedcohortstudy
AT chenhueyyi longtermtherapywithwulingsanapopularantilithicchineseherbalformuladidnotpreventsubsequentstonesurgeryanationwidepopulationbasedcohortstudy
AT tsaikaosung longtermtherapywithwulingsanapopularantilithicchineseherbalformuladidnotpreventsubsequentstonesurgeryanationwidepopulationbasedcohortstudy
AT chiangjenhuai longtermtherapywithwulingsanapopularantilithicchineseherbalformuladidnotpreventsubsequentstonesurgeryanationwidepopulationbasedcohortstudy
AT muochihhsin longtermtherapywithwulingsanapopularantilithicchineseherbalformuladidnotpreventsubsequentstonesurgeryanationwidepopulationbasedcohortstudy
AT sungfungchang longtermtherapywithwulingsanapopularantilithicchineseherbalformuladidnotpreventsubsequentstonesurgeryanationwidepopulationbasedcohortstudy
AT chenyunghsiang longtermtherapywithwulingsanapopularantilithicchineseherbalformuladidnotpreventsubsequentstonesurgeryanationwidepopulationbasedcohortstudy
AT chenwenchi longtermtherapywithwulingsanapopularantilithicchineseherbalformuladidnotpreventsubsequentstonesurgeryanationwidepopulationbasedcohortstudy